13 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18934187 | SKIN CARE FOR EXTREMELY LOW BIRTHWEIGHT INFANTS | ALBERS, KEVIN S | 3786 | Final Rejection | Oct 31, 2024 |
| 18252813 | REFINED USES OF GABA A RECEPTOR MODULATORS IN TREATMENT OF FRAGILE X SYNDROME | WHITE, DENNIS MICHAEL | 1758 | Non-Final OA | May 12, 2023 |
| 18250996 | PSEUDOTYPED PARTICLES, MODIFIED CELLS, RELATED COMPOSITIONS, AND RELATED METHODS | O'NEILL, MARISOL ANN | 1633 | Non-Final OA | Apr 28, 2023 |
| 18029863 | ORGANOID RECOMBINATION | KNIGHT, TERESA E | 1634 | Non-Final OA | Mar 31, 2023 |
| 17997264 | Precision Dosing Regimen | BABIC, CHRISTOPHER M | 1633 | Final Rejection | Oct 27, 2022 |
| 17919030 | Systems and Methods for Quantification of Liver Fibrosis with MRI and Deep Learning | REINIER, BARBARA DIANE | 2682 | Final Rejection | Oct 14, 2022 |
| 17910105 | MATERIALS AND METHODS FOR THE TREATMENT OF GAUCHER DISEASE | CURRENS, GRANT CARSON | 1651 | Final Rejection | Sep 08, 2022 |
| 17778188 | CELA-1 INHIBITION FOR TREATMENT OF LUNG DISEASE | WEN, SHARON X | 1641 | Non-Final OA | May 19, 2022 |
| 17627613 | METHOD OF TREATING NEOPLASTIC DISEASES WITH A CDC42-SPECIFIC INHIBITOR | PUTTLITZ, KARL J | 1646 | Non-Final OA | Jan 14, 2022 |
| 17603774 | VIRAL VECTOR MANUFACTURING METHODS | JADHAO, SAMADHAN JAISING | 1672 | Final Rejection | Oct 14, 2021 |
| 17432656 | METHODS AND COMPOSITIONS FOR THE DETECTION, CLASSIFICATION, AND DIAGNOSIS OF CHRONIC POST-SURGICAL PAIN | SISSON, BRADLEY L | 1682 | Final Rejection | Aug 20, 2021 |
| 17421908 | COMPOSITIONS AND METHODS FOR TREATMENT OF A MALABSORPTIVE DISORDER | REGLAS, GILLIAN CHELSEA | 1632 | Final Rejection | Jul 09, 2021 |
| 16967441 | METHODS FOR TREATING FIBROSIS | PIHONAK, SARAH | 1627 | Final Rejection | Aug 05, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial